3-(5'-Amino-4'-carbethoxy-3'-isoxazolyl)indole | 95094-70-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 3-(5'-Amino-4'-carbethoxy-3'-isoxazolyl)indole
• 英文别名: ethyl 5-amino-3-(1H-indol-3-yl)-1,2-oxazole-4-carboxylate
• CAS: 95094-70-5
• 化学式: C₁₄H₁₃N₃O₃
• 分子量: 271.276
• InChiKey: IBWDALILUVGHRQ-UHFFFAOYSA-N

物化性质

• 熔点：
  360 °C
• 沸点：
  568.6±50.0 °C(Predicted)
• 密度：
  1.357±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  94.1
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  1-Chloro-N-hydroxy-1-(3H-indol-3-ylidene)methanamine 、 氰乙酸乙酯 在 sodium ethanolate 作用下， 生成 3-(5'-Amino-4'-carbethoxy-3'-isoxazolyl)indole
  参考文献：
  名称：

  Hiremath, Shivayogi P.; Thakar, Shreeram B.; Purohit, Muralidhar G., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1984, vol. 23, # 10, p. 926 - 929

  摘要：

  DOI：

文献信息

• Aminoisoxazole derivatives active as kinase inhibitors
  申请人：Cavicchioli Marcello

  公开号：US20050059657A1

  公开（公告）日：2005-03-17

  Compounds (I) which are aminoisoxazole derivatives or pharmaceutically acceptable salts thereof, together with pharmaceutical compositions comprising them are disclosed; these compounds or compositions are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.

  本发明涉及氨基异噁唑衍生物(I)或其药学上可接受的盐，以及包含它们的药物组合物。这些化合物或组合物在治疗由蛋白激酶活性改变引起和/或相关的疾病方面具有用途，例如癌症、细胞增殖性疾病、阿尔茨海默病、病毒感染、自身免疫性疾病和神经退行性疾病。
• HIREMATH, SHIVAYOGI, P.;THAKAR, SHREERAM, B.;PUROHIT, MURALIDHAR, G., INDIAN J. CHEM., 1984, 23, N 10, 926-929
  作者：HIREMATH, SHIVAYOGI, P.、THAKAR, SHREERAM, B.、PUROHIT, MURALIDHAR, G.

  DOI：——

  日期：——
• AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
  申请人：Pharmacia Italia S.p.A.

  公开号：EP1435948A1

  公开（公告）日：2004-07-14
• [EN] AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS<br/>[FR] DÉRIVÉS D'AMINOISOXAZOLE AGISSANT COMME INHIBITEURS DE LA KINASE
  申请人：PHARMACIA ITALIA SPA

  公开号：WO2003013517A1

  公开（公告）日：2003-02-20

  Compounds (I) which are aminoisoxazole derivatives or pharmaceutically acceptable salts thereof, together with pharmaceutical compositions comprising them are disclosed; these compounds or compositions are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.